Glial fibrillary acidic protein in Guillain-Barré syndrome: Methodological issues

Muscle and Nerve

Volumn 39, Issue 5, 2009, Pages 711-712

  Petzold, A ^a   Rosengren, L ^b   Verbeek, M M ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

BLOOD SAMPLING; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; LETTER; LUMBAR PUNCTURE; NERVE BLOCK; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED;

EID: 65949095662     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21283     Document Type: Letter

References (5)

1. Notturno F, Caporale CM, De Lauretis A, Uncini A. Glial fibrillary acidic protein: a marker of axonal Guillain-Barré syndrome and outcome. Muscle Nerve 2008;38:899-903.
2. Petzold A, Keir G, Green AJE, Giovannoni G, Thompson EJ. An ELISA for glial fibrillary acidic protein. J Immunol Methods 2004;287:169-177. (Pubitemid 38510218)
3. Petzold A, Brettschneider J, Jin K, Keir G, Murray NMF, Hirsch NP, et al. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré Syndrome. Muscle Nerve (to be published).
4. Rosengren LE, Wikkelso C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Methods 1994;51:197-204. (Pubitemid 24110093)
5. Van Geel WJ, de Reus HPM, Nijzing H, Verbeek MM, Vos PE, Lamers KJ. Measurement of glial fibrillary acidic protein in blood: an analytical method. Clin Chim Acta 2002;326:151-154. (Pubitemid 35341172)